On the contrary, EAE mice administered with RR-MS patients or donors hPDLSCs-CM and EMVs showed significant reduction in STAT1, p53, cleaved caspase 3 and Bax expressions. This evidence concerns the gene CASP3 and myeloid sarcoma.